WALTHAM, Mass., May 12, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced it has initiated a discovery program for a measles monoclonal antibody (mAb). Multiple healthcare ...

Outlines broad discovery and development efforts targeting synthetic lethality and DNA-damage repair mechanisms, including PRMT5-MTA, SGR-3515 and SGR-2921 programs NEW YORK--(BUSINESS ...

STAMFORD, Conn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Summer Discovery, a leading pre-college enrichment program, has announced its first partnership with the UBC Sauder School of Business, opening ...

Strategic partnership includes co-development of patient-derived xenograft (PDX) Digital Twins for in vivo oncology research Charles River to make an equity investment in Aitia as part of the ...